𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacy

✍ Scribed by Brigette Ma; Edwin P. Hui; Ann King; K. F. To; Frankie Mo; Sing F. Leung; Michael Kam; Y. M. Dennis Lo; Benny Zee; Tony Mok; Anil Ahuja; Anthony T. C. Chan

Book ID
105992729
Publisher
Springer
Year
2007
Tongue
English
Weight
287 KB
Volume
62
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of plasma Epstein–Barr virus
Comparison of plasma Epstein–Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma
✍ Jian-Yong Shao; Yu-Hong Li; Hong-Yi Gao; Qiu-Liang Wu; Nian-Ji Cui; Li Zhang; Ga 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 2 views

## Abstract ## BACKGROUND Serologic measurement of antibodies to Epstein–Barr virus (EBV) immunoglobulin A/viral capsid antigen (IgA/VCA) and early antigen (IgA/EA) has been used widely to screen for nasopharyngeal carcinoma (NPC) in China. Recently, it was found that plasma EBV DNA concentration